Differential response of head and neck cancer cell lines to TRAIL or Smac mimetics is associated with the cellular levels and activity of caspase-8 and caspase-10

BACKGROUND: Current treatment strategies for head and neck cancer are associated with significant morbidity and up to 50% of patients relapse, highlighting the need for more specific and effective therapeutics. Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and Smac mimetics (SMs)...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Br J Cancer
Glavni autori: Raulf, N, El-Attar, R, Kulms, D, Lecis, D, Delia, D, Walczak, H, Papenfuss, K, Odell, E, Tavassoli, M
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2014
Teme:
Translational Therapeutics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4229641/
https://ncbi.nlm.nih.gov/pubmed/25314064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.521
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items